2022
De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report
Gandhi S, Klein J, Robertson AJ, Peña-Hernández MA, Lin MJ, Roychoudhury P, Lu P, Fournier J, Ferguson D, Mohamed Bakhash SAK, Catherine Muenker M, Srivathsan A, Wunder EA, Kerantzas N, Wang W, Lindenbach B, Pyle A, Wilen CB, Ogbuagu O, Greninger AL, Iwasaki A, Schulz WL, Ko AI. De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report. Nature Communications 2022, 13: 1547. PMID: 35301314, PMCID: PMC8930970, DOI: 10.1038/s41467-022-29104-y.Peer-Reviewed Original ResearchConceptsSARS-CoV-2 infectionVirologic responsePersistent SARS-CoV-2 infectionResistance mutationsPre-treatment specimensB-cell deficiencyRemdesivir resistanceRemdesivir therapyViral sheddingCase reportAntiviral agentsPatientsCombinatorial therapyInfectionTherapyWhole-genome sequencingTreatmentImportance of monitoringDe novo emergenceFold increaseRNA-dependent RNA polymeraseNovo emergencePotential benefitsMutationsIndolent
2015
Markers of Intestinal Inflammation for the Diagnosis of Infectious Gastroenteritis
Gonzalez MD, Wilen CB, Burnham CA. Markers of Intestinal Inflammation for the Diagnosis of Infectious Gastroenteritis. Clinics In Laboratory Medicine 2015, 35: 333-344. PMID: 26004646, DOI: 10.1016/j.cll.2015.02.001.Peer-Reviewed Original ResearchConceptsInfectious gastroenteritisIntestinal inflammationSystemic biomarkersInfectious diarrheaInvasive testingFecal biomarkersParasitic infectionsHost responseMajor causeGastroenteritisDiagnosisAdjunct diagnosticsStand-alone testsBiomarkersAssaysInexpensive assayMorbidityDiarrheaInflammationTherapyInfection